Reported Tuberculosis in the United States, 2021

Return to Main Menu

Table 44. Tuberculosis Cases and Percentages by Initial Drug Regimen: Reporting Areas, 2021

Tuberculosis cases and percentages by initial drug regimen and reporting area.
Reporting area Total cases1 Initial drug regimen data available Multi (4+) drug regimen2 HRZE3
No. (%) No. (%) No. (%)
United States4 7,621 7,604 (99.8) 794 (10.4) 6,330 (83.2)
Alabama 90 90 (100.0) 16 (17.8) 67 (74.4)
Alaska 56 54 (96.4) 4 (7.4) 48 (88.9)
Arizona 125 125 (100.0) 4 (3.2) 116 (92.8)
Arkansas 67 67 (100.0) 2 (3.0) 58 (86.6)
California 1,701 1,701 (100.0) 152 (8.9) 1,424 (83.7)
Colorado 58 58 (100.0) 3 (5.2) 46 (79.3)
Connecticut 53 53 (100.0) 7 (13.2) 46 (86.8)
Delaware 36 36 (100.0) 3 (8.3) 33 (91.7)
District of Columbia 17 17 (100.0) 1 (5.9) 16 (94.1)
Florida 487 487 (100.0) 43 (8.8) 414 (85.0)
Georgia 211 211 (100.0) 107 (50.7) 76 (36.0)
Hawaii 102 102 (100.0) 6 (5.9) 94 (92.2)
Idaho 5 5 (100.0) 1 (20.0) 3 (60.0)
Illinois 245 245 (100.0) 10 (4.1) 216 (88.2)
Indiana 123 121 (98.4) 9 (7.4) 108 (89.3)
Iowa 49 49 (100.0) 1 (2.0) 48 (98.0)
Kansas 41 41 (100.0) 9 (22.0) 32 (78.0)
Kentucky 57 57 (100.0) 8 (14.0) 48 (84.2)
Louisiana 81 81 (100.0) 4 (4.9) 73 (90.1)
Maine 14 14 (100.0) 1 (7.1) 13 (92.9)
Maryland 190 186 (97.9) 14 (7.5) 171 (91.9)
Massachusetts 148 148 (100.0) 20 (13.5) 114 (77.0)
Michigan 134 134 (100.0) 5 (3.7) 125 (93.3)
Minnesota 131 131 (100.0) 8 (6.1) 105 (80.2)
Mississippi 43 42 (97.7) 1 (2.4) 36 (85.7)
Missouri 76 76 (100.0) 8 (10.5) 63 (82.9)
Montana 3 3 (100.0) 0 (0.0) 3 (100.0)
Nebraska 22 21 (95.5) 4 (19.0) 17 (81.0)
Nevada 56 56 (100.0) 5 (8.9) 49 (87.5)
New Hampshire 12 12 (100.0) 5 (41.7) 7 (58.3)
New Jersey 283 280 (98.9) 6 (2.1) 260 (92.9)
New  Mexico 22 22 (100.0) 1 (4.5) 16 (72.7)
New York State5 146 145 (99.3) 17 (11.7) 120 (82.8)
New York City 516 516 (100.0) 52 (10.1) 441 (85.5)
North Carolina 171 171 (100.0) 40 (23.4) 128 (74.9)
North Dakota 15 15 (100.0) 4 (26.7) 11 (73.3)
Ohio 146 146 (100.0) 29 (19.9) 109 (74.7)
Oklahoma 67 67 (100.0) 6 (9.0) 45 (67.2)
Oregon 75 75 (100.0) 4 (5.3) 67 (89.3)
Pennsylvania 157 155 (98.7) 22 (14.2) 129 (83.2)
Rhode Island 17 17 (100.0) 1 (5.9) 16 (94.1)
South Carolina 81 81 (100.0) 7 (8.6) 67 (82.7)
South Dakota 12 12 (100.0) 7 (58.3) 5 (41.7)
Tennessee 81 80 (98.8) 5 (6.3) 70 (87.5)
Texas 960 960 (100.0) 63 (6.6) 828 (86.3)
Utah 17 17 (100.0) 1 (5.9) 16 (94.1)
Vermont 3 3 (100.0) 0 (0.0) 3 (100.0)
Virginia 156 156 (100.0) 15 (9.6) 138 (88.5)
Washington 193 193 (100.0) 46 (23.8) 135 (69.9)
West Virginia 6 6 (100.0) 0 (0.0) 6 (100.0)
Wisconsin 61 61 (100.0) 5 (8.2) 51 (83.6)
Wyoming 3 3 (100.0) 2 (66.7) 0 (0.0)
American Samoa 4 4 (100.0) 4 (100.0) 0 (0.0)
Federated States of Micronesia 71 71 (100.0) 0 (0.0) 70 (98.6)
Guam 56 56 (100.0) 27 (48.2) 29 (51.8)
Republic of the Marshall Islands 118 118 (100.0) 1 (0.8) 117 (99.2)
Northern Mariana Islands 35 35 (100.0) 0 (0.0) 34 (97.1)
Puerto Rico 18 18 (100.0) 0 (0.0) 18 (100.0)
Republic of Palau 6 6 (100.0) 2 (33.3) 4 (66.7)
U.S. Virgin Islands 2 2 (100.0) 2 (100.0) 0 (0.0)

1Persons alive at diagnosis.
2A drug regimen with at least four drugs other than HRZE.
3H, isoniazid; R, rifampin; Z, pyrazinamide; E, ethambutol.
4American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.
5Excludes New York City.

Note:
In 2021, 70 (0.9%) received no initial drug therapy and 20 (0.3%) were started on one drug in the 50 U.S. states, New York City, and District of Columbia.